Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION
Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
NAION produces an ischemic insult in the optic nerve head presumably due to the hypoperfusion
of the short ciliary arteries that supply it.
Intravenous injection of glucocorticoid have proven to be effective in treatment of
Nonarteritic Anterior Ischemic Optic Neuropathy,but have some side effects. the investigators
believe that offering them Retrobulbar Triamcinolone Acetonide Injection that might halt the
progression of the visual acuity and visual field loss if our hypothesis is correct, would
greatly improve their chances of avoiding blindness.